Vision After Cataract Surgery: What You Need to Know About AMD and PCV
"Exploring the impact of cataract surgery on patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy."
A recent study highlighted that cataract surgery can lead to improved vision for individuals with neovascular age-related macular degeneration (AMD). Following cataract surgery, patients experienced an improvement in visual acuity, as measured by ETDRS letters. This is encouraging news, as it suggests a potential benefit for those with both cataracts and neovascular AMD.
However, the study also revealed a nuanced picture. While cataract surgery didn't alter the overall frequency of anti-VEGF (vascular endothelial growth factor) injections, a closer look showed that some patients who had been injection-free for over a year prior to cataract surgery needed to resume these injections afterward. Specifically, among 19 patients, 11 required a resumption of anti-VEGF treatment.
This observation raises an important question: are there specific clinical factors or features detectable on optical coherence tomography (OCT) that could help predict which patients might require renewed anti-VEGF injections after cataract surgery? Identifying these factors would be invaluable in optimizing treatment strategies and managing patient expectations.
Cataract Surgery When AMD Is Present
Cataracts and age-related macular degeneration (AMD) commonly occur together in people over age 50, and both can reduce vision. Cataract surgery treats vision loss caused by the cataract, but clinicians have raised questions about how surgery relates to AMD. Proposed explanations for a possible connection include light toxicity, indirect surgical trauma, and inflammatory mediators; other studies have found no association with wet AMD progression. The evidence on a relationship between cataract surgery and AMD remains conflicting, according to Retina Today.
PCV and the Risk of Submacular Hemorrhage
It's important to consider the presence of polypoidal choroidal vasculopathy (PCV), a subtype of AMD that occurs more frequently in Asian populations. One potential complication of active PCV is the development of sudden, massive submacular hemorrhage, which can lead to permanent vision loss.
- Intraocular pressure is known to fluctuate during cataract surgery.
- Shearing forces resulting from these pressure changes may damage choroidal vessels.
- Patients with hypertension and arteriosclerosis may be particularly vulnerable due to increased vessel fragility.
A Possible Pressure-Related Risk
In patients with neovascular AMD, the risk factors for massive submacular haemorrhage remain uncertain. The source reports that a sudden change in intraocular pressure is believed to be one factor that may precipitate such a haemorrhage. This is presented as a possible factor, not a settled explanation for these events.
What Studies Report About Progression Risk
The American Academy of Ophthalmology reports that AREDS2 followed participants with AMD for up to 10 years and found no increased risk of AMD progression or worsening among those who had cataract surgery compared with those who did not. A separate large retrospective cohort study likewise found similar neovascular AMD risk in patients who did and did not undergo cataract surgery. That cohort also observed decreased conversion risk at 3 months among patients with non-neovascular AMD, a finding specific to that time point. These results address risk comparisons; they do not mean cataract surgery prevents AMD.
Optimizing Care for AMD and PCV Patients
Cataract surgery can be beneficial for patients with AMD, but careful consideration is necessary, especially in those with PCV. Assessing the activity level of PCV lesions is crucial in determining the optimal management strategy before proceeding with cataract surgery.
Visual Outcomes Depend on the Macula
AMD and cataracts often coexist because age is a major risk factor for both, and both can substantially reduce visual acuity. One study set out to assess cataract surgery’s effects on visual acuity, retinal morphology, and VEGF inhibitor therapy in patients with AMD. A review on cataract surgery in the context of AMD notes that visual function can improve substantially, while outcomes are influenced by the type and severity of the underlying macular pathology.
Interpreting Conversion-Risk Findings
A reported analysis considered AMD stage before surgery but noted a potential selection bias: eyes that do not undergo cataract surgery may have more advanced disease and higher baseline conversion risk. If healthier eyes were more likely to receive surgery, the surgery group could appear to have a lower conversion risk for that reason. This caveat matters when interpreting observed differences between surgical and nonsurgical groups.
Quality of Life and Vision After Surgery
A prospective, interventional, single-center study examined whether people with severe vision impairment from advanced AMD benefit from bilateral cataract surgery in terms of vision-related quality of life. A separate study evaluated visual acuity outcomes, prognostic factors, and changes in AMD severity among patients undergoing cataract surgery. Together, these study aims highlight that patient impact is considered through both quality-of-life and clinical vision outcomes.
Further research is needed to identify clinical factors and OCT features that can predict the need for resumed anti-VEGF injections after cataract surgery. Understanding these factors will enable ophthalmologists to better tailor treatment plans and monitor patients at higher risk.
By carefully evaluating each patient's individual circumstances, including the presence and activity of PCV, ophthalmologists can optimize visual outcomes and minimize the risk of complications following cataract surgery.